By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Arch Therapeutics 

1 Chieftain Lane

Natick  Massachusetts  01760  U.S.A.
Phone: 617-475-5254 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
Arch Therapeutics $6.1 Million Registered Direct Offering 2/22/2017 7:19:48 AM
Arch Therapeutics Provides Corporate Milestone Update, Including Anticipated Filing Of 510(k) For AC5 2/17/2017 8:35:42 AM
Arch Therapeutics Announces Issuance Of Method-Of-Use Patent Covering Self-Assembling Peptidomimetics 2/3/2017 11:12:07 AM
Arch Therapeutics Reports AC5 Topical Hemostatic Device Successfully Stopped Bleeding In Patients On Antiplatelet Therapy In Recently Completed Clinical Study 11/1/2016 12:45:39 PM
Arch Therapeutics Will Present At The 2016 BIO Investor Forum In San Francisco, California October 18-19th, 2016 10/12/2016 2:02:01 PM
Arch Therapeutics Will Present At The 2016 Aegis Capital Growth Conference In Las Vegas, NV September 20-22, 2016 9/16/2016 11:45:29 AM
Arch Therapeutics Provides Corporate Update At The 18th Annual Rodman & Renshaw Global Investment Conference 9/13/2016 11:32:52 AM
Arch Therapeutics Will Present 18th Annual Rodman & Renshaw Global Investment Conference In New York City September 11-13th, 2016 8/23/2016 11:25:30 AM
Arch Therapeutics' President And CEO, Terrence Norchi, MD, Featured On "Small Cap Spotlight" Podcast Broadcasted Globally On Publicwire 8/22/2016 9:26:39 AM
Arch Therapeutics Reports AC5 Topical Hemostatic Device Meets Primary And Secondary Endpoints In First Clinical Study 8/15/2016 12:48:29 PM
123456789
//-->